Indications and uses
Nystatin Ointment is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida [Monilia] albicans and other Candida species.
Nystatin Ointment is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida [Monilia] albicans and other Candida species.
Nystatin Ointment should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with nystatin topical powder. This preparation does not stain skin or mucous membranes and provides a simple, convenient means of treatment.
Rx only
Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is a polyene antibiotic that is obtained from Streptomyces noursei, and is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida [Monilia]albicans and other Candida species. It exhibits no appreciable activity against bacteria.
Nystatin provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.
Nystatin Ointment is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida [Monilia]albicans and other Candida species.
Nystatin Ointment is contraindicated in patients with a history of hypersensitivity to any of its components.
Should a reaction of hypersensitivity occur the drug should be immediately withdrawn and appropriate measures taken.
This preparation is not for ophthalmic use.
Nystatin is virtually non-toxic and nonsensitizing and is well tolerated by all age groups including debilitated infants, even on prolonged administration. If irritation on topical application should occur, discontinue medication.
Nystatin Ointment should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with nystatin topical powder.
This preparation does not stain skin or mucous membranes and provides a simple, convenient means of treatment.
Nystatin Ointment (100,000 USP Nystatin Units per gram) is a yellow ointment available as follows:
NDC 42254-284-15 15 gram tube
Store at controlled room temperature 15°- 30°C (59°-86°F).
E. FOUGERA & CO.
A division of Fougera Pharmaceuticals Inc.
Melville, New York 11747
I20715H
R08/11
#21
Repackaged by:
REBEL DISTRIBUTORS CORP.
Thousand Oaks, CA 91320
| Class | Version | Type | Effective |
|---|---|---|---|
| NYSTATIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e29fe634-dc25-094c-c77f-5d09c3eceb3e | Product name | 5 | 20260107 |
| e57b6340-9387-3f9a-7307-511c81791375 | Product name | 3 | 20221214 |
| 544f8e8d-6389-eeeb-9586-aa447c08dcc7 | Product name | 5 | 20210614 |
| 1629e00f-54fb-4a43-8306-b58442b23902 | Product name | 9 | 20200430 |
| 854ec07b-1cd7-a5db-235a-7aa24d3cf97a | Product name | 3 | 20180628 |
| 19b9f4c1-15e9-edcc-4c16-f01ecfb5c549 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42254-284-15 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3d49-c013-e053-90daa90a1393 | NYSTATIN OINTMENT USP |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42254-284-15 | Nystatin | 15 g in 1 TUBE | OINTMENT | 15 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42254-284-15 | GM - Gram | 42254-284 | 6c62d2f1-8e50-49f6-bf24-ab4c21f6e627 | 1 | 2013-04-01 |
| 0168-0007-15 | GM - Gram | 0168-0007 | 52751ca1-1910-4597-8fa6-faa22e9bacab | 1 | 2012-07-24 |
| 0168-0007-30 | GM - Gram | 0168-0007 | e865dc45-e1a9-4f36-b7cc-2aa04b9958ec | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| nystatin | ACTIVE INGREDIENT | BDF1O1C72E | 1 | |
| nystatin | ACTIVE MOIETY | BDF1O1C72E | 1 | |
| HIGH DENSITY POLYETHYLENE | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 42254-284 | 42254-284-15 |
| 0168-0007 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| nystatin | BDF1O1C72E | ACTIB |
| HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | IACT |
| Mineral Oil | T5L8T28FGP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | OINTMENT / OPHTHALMIC | NA | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | PASTE / DENTAL | 60 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | GEL / TOPICAL | 26 %w/w | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CAPSULE, EXTENDED RELEASE / ORAL | 4.53 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET, COATED / ORAL | 25 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | PASTE / TOPICAL | 2.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET / ORAL | 50 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TAPE / TOPICAL | NA | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SUPPOSITORY / VAGINAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SYSTEM / TRANSDERMAL | NA | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SUPPOSITORY / RECTAL | NA | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CREAM / TOPICAL | 54.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET, EXTENDED RELEASE / ORAL | 0.64 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | OINTMENT / TOPICAL | 94 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | JELLY / VAGINAL | 42.6 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CAPSULE / ORAL | 10 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | FILM, EXTENDED RELEASE / TRANSDERMAL | 85 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET, DELAYED RELEASE / ORAL | NA |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062124-002 | NYSTATIN | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 |
| Application-product | TE code |
|---|---|
| A062124-002 | AT |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | f41ea6bd6efb… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A062124-002 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A062124-002 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A062124-002 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062124-002 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062124-002 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062124-002 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062124-002 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062124-002 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062124-002 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062124-002 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062124-002 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062124-002 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062124-002 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062124-002 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062124-002 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A062124-002 | AT | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062124-002 | AT | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A062124-002 | AT | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A062124-002 | AT | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A062124-002 | AT | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A062124-002 | AT | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A062124-002 | AT | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062124-002 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A062124-002 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A062124-002 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A062124-002 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A062124-002 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A062124-002 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A062124-002 | AT | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062124-002 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A062124-002 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A062124-002 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062124-002 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062124-002 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062124-002 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062124-002 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A062124-002 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A062124-002 | AT | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062124-002 | AT | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A062124-002 | AT | 1 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| da4cd3fc-906d-4468-b7f9-c20f085c95ed | da4cd3fc-906d-4468-b7f9-c20f085c95ed | 2012-08-28 | Adverse reactions | da4cd3fc-906d-4468-b7f9-c20f085c95ed da4cd3fc-906d-4468-b7f9-c20f085c95ed |
Adverse event summaries are temporarily unavailable. Other product information remains available.